생명과학회지 (Journal of Life Science)

  • 제16권7호
  • /
  • Pages.1207-1213
  • /
  • 2006
  • /
  • 1225-9918(pISSN)
  • /
  • 2287-3406(eISSN)
한국생명과학회 (Korean Society of Life Science)
권호 표지
DOI QR코드

DOI QR Code

Tumor necrosis factor-α에 의한 골수 유래 중간엽 줄기세포의 골세포로의 분화 촉진에서 JNK의 역할

Tumor Necrosis factor-α Promotes Osteogenesis of Human Bone Marrow-derived Mesenchymal Stem Cells through JNK-dependent Pathway

  • 김미라 (부산대학교 의과대학 생리학교실) ;
  • 송해영 (부산대학교 의과대학 생리학교실) ;
  • 김재호 (부산대학교 의과대학 생리학교실)
  • Kim, Mi-Ra (Medical Research Center for Ischemic Tissue Regeneration & Medical Research Institute) ;
  • Song, Hae-Young (Medical Research Center for Ischemic Tissue Regeneration & Medical Research Institute) ;
  • Kim, Jae-Ho (Medical Research Center for Ischemic Tissue Regeneration & Medical Research Institute)
  • 발행 : 2006.12.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Tumor necrosis $factor-{\alpha}\;(TNF-{\alpha})$는 염증성 골질환에서의 골조직의 손실과 밀접한 관련이 있다. 본 연구에서는 인체 골수 유래 중간엽 줄기세포의 골세포로의 분화과정에 대한 $TNF-{\alpha}$의 영향을 조사하였다. $TNF-{\alpha}$는 골수 유래 중간엽 줄기세포의 골세포로의 분화를 나타내는 표시인 세포외 무기질 축적과 alkaline phosphatase의 발현의 증가를 일으켰으며 2ng/ml의 농도에서 최대의 증가를 나타내었다. $TNF-{\alpha}$에 의한 골세포로의 분화는 $NF_kB$의 저해제에 의해서는 영향받지 않았으나 JNK 특이 저해제인 SP600125에 의해 완벽하게 억제되었다. 이는 $TNF-{\alpha}$에 의한 골수 유래 중간엽 줄기세포의 골세포로의 분화과정에 JNK가 중요한 역할을 한다는 것을 제시한다.

Tumor necrosis $factor-{\alpha}\;(TNF-{\alpha})$ has been implicated in skeletal diseases by promoting bone loss in inflammatory bone diseases. In the present study, we examined the effects of $TNF-{\alpha}$ on osteoblastic differentiation of human bone marrow-derived mesenchymal stem cells (hBMSCs). $TNF-{\alpha}$ dose-dependently promoted matrix mineralization of hBMSCs with a maximal stimulation at 2ng/ml. $TNF-{\alpha}$ increased expression of alkaline phosphatase, which plays a crucial role for the matrix deposition. The $TNF-{\alpha}-stimulated$ osteoblastic differentiation was not affected by $NF_kB$ inhibitors, BAY and SN50. However, a JNK-specific inhibitor, SP600125 completely abolished the $TNF-{\alpha}-stimulated$ matrix mineralization and expression of alkaline phosphatase. These results suggest that $TNF-{\alpha}$ enhances osteoblastic differentiation of hBMSCs through JNK-dependent pathway.

키워드

참고문헌

  1. Abbas, S., Y. H. Zhang, J. C. Clohisy, and Y. Abu-Amer. 2003. Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Cytokine 22, 33-41 https://doi.org/10.1016/S1043-4666(03)00106-6
  2. Barry, F. P. and J. M. Murphy. 2004. Mesenchymal stem cells: clinical applications and biological characterization. Int. J. Biochem. Cell Biol. 36, 568-584 https://doi.org/10.1016/j.biocel.2003.11.001
  3. Beresford, J. N., J. H. Bennett, C. Devlin, P. S. Leboy, and M. E. Owen. 1992. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures. J. Cell Sci. 102 (Pt 2), 341-351
  4. Canalis, E. 1987. Effects of tumor necrosis factor on bone formation in vitro. Endocrinology 121, 1596-1604 https://doi.org/10.1210/endo-121-5-1596
  5. Caplan, A. I. 1991. Mesenchymal stem cells. J. Orthop. Res. 9, 641-650 https://doi.org/10.1002/jor.1100090504
  6. Centrella, M., T. L. McCarthy, and E. Canalis. 1988. Tumor necrosis factor-alpha inhibits collagen synthesis and alkaline phosphatase activity independently of its effect on deoxyribonucleic acid synthesis in osteoblast-enriched bone cell cultures. Endocrinology 123, 1442-1448 https://doi.org/10.1210/endo-123-3-1442
  7. Chen, G. and D. V. GoeddeL 2002. TNF-R1 signaling: a beautiful pathway. Science 296, 1634-1635 https://doi.org/10.1126/science.1071924
  8. Clohisy, J. C., S. Teitelbaum, S. Chen, J. M. Erdmann, and Y. Abu-Amer. 2002. Tumor necrosis factor-alpha mediates polymethylmethacrylate particle-induced NF-kappaB activation in osteoclast precursor cells. J. Orthop. Res. 20, 174-181 https://doi.org/10.1016/S0736-0266(01)00088-2
  9. Farley, J. R. and B. Stilt-Coffing. 2001. Apoptosis may determine the release of skeletal alkaline phosphatase activity from human osteoblast-line cells. Calcif. Tissue Int. 68, 43-52 https://doi.org/10.1007/BF02685002
  10. Filvaroff, E. and R. Derynck. 1998. Bone remodelling: a signalling system for osteoclast regulation. Curr. Biol. 8, R679-R682 https://doi.org/10.1016/S0960-9822(98)70434-8
  11. Gerstenfeld, L. C., T. J. Cho, T. Kon, T. Aizawa, J. Cruceta, B. D. Graves, and T. A. Einhorn. 2001. Impaired intramembranous bone formation during bone repair in the absence of tumor necrosis factor-alpha signaling. Cells Tissues. Organs 169, 285-294 https://doi.org/10.1159/000047893
  12. Gilbert, L., X. He, P. Farmer, S. Boden, M. Kozlowski, J. Rubin, and M. S. Nanes. 2000. Inhibition of osteoblast differentiation by tumor necrosis factor-alpha. Endocrinology 141, 3956-3964 https://doi.org/10.1210/en.141.11.3956
  13. Goldring, S. R. and E. M. Gravallese. 2000. Pathogenesis of bone erosions in rheumatoid arthritis. Curr. Opin. Rheumatol. 12, 195-199 https://doi.org/10.1097/00002281-200005000-00006
  14. Guicheux, J., J. Lemonnier, C. Ghayor, A. Suzuki, G. Palmer, and J. Caverzasio. 2003. Activation of p38 mitogen-activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J. Bone Miner. Res. 18, 2060-2068 https://doi.org/10.1359/jbmr.2003.18.11.2060
  15. Kuroki, T., M. Shingu, Y. Koshihara, and M. Nobunaga. 1994. Effects of cytokines on alkaline phosphatase and osteocalcin production, calcification and calcium release by human osteoblastic cells. Br. J. Rheumatol. 33, 224-230 https://doi.org/10.1093/rheumatology/33.3.224
  16. Lee, R. H., B. Kim, I. Choi, H. Kim, H. S. Choi, K. Suh, Y. C. Bae, and J. S. Jung. 2004. Characterization and expression analysis of mesenchymal stem cells from human bone marrow and adipose tissue. Cell Physiol Biochem. 14, 311-324 https://doi.org/10.1159/000080341
  17. Li, Y. P. and P. Stashenko. 1992. Proinflammatory cytokines tumor necrosis factor-alpha and IL-6, but not IL-1, down-regulate the osteocalcin gene promoter. J. Immunol. 148, 788-794
  18. Manji, S. S., H. Zhou, D. M. Findlay, T. J. Martin, and K. W. Ng. 1995. Tumor necrosis factor alpha facilitates nuclear actions of retinoic acid to regulate expression of the alkaline phosphatase gene in preosteoblasts. J. Biol. Chem. 270, 8958-8962 https://doi.org/10.1074/jbc.270.15.8958
  19. Merkel, K. D., J. M. Erdmann, K. P. McHugh, Y. Abu-Amer, F. P. Ross, and S. L. Teitelbaum. 1999. Tumor necrosis factor-alpha mediates orthopedic implant osteolysis. Am. J. Pathol. 154, 203-210 https://doi.org/10.1016/S0002-9440(10)65266-2
  20. Nakase, T., K. Takaoka, K. Masuhara, K. Shimizu, H. Yoshikawa, and T. Ochi. 1997. Interleukin-1 beta enhances and tumor necrosis factor-alpha inhibits bone morphogenetic protein-2-induced alkaline phosphatase activity in MC3T3-E1 osteoblastic cells. Bone 21, 17-21 https://doi.org/10.1016/S8756-3282(97)00038-0
  21. Panagakos, F. S. and S. Kumar. 1994. Modulation of proteases and their inhibitors in inunortal human osteoblast-like cells by tumor necrosis factor-alpha in vitro. Inflammation 18, 243-265 https://doi.org/10.1007/BF01534267
  22. Pittenger, M. F., A. M. Mackay, S. C. Beck, R. K. Jaiswal, R. Douglas, J. D. Mosca, M. A. Moorman, D. W. Simonetti, S. Craig, and D. R. Marshak. 1999. Multilineage potential of adult human mesenchymal stem cells. Science 284, 143-147 https://doi.org/10.1126/science.284.5411.143
  23. Prockop, D. J. 1997. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 276, 71-74 https://doi.org/10.1126/science.276.5309.71
  24. Short, B., N. Brouard, T. Occhiodoro-Scott, A. Ramakrishnan, and P. J. Simmons. 2003. Mesenchymal stem cells. Arch. Med. Res. 34, 565-571 https://doi.org/10.1016/j.arcmed.2003.09.007
  25. Stashenko, P., M. S. Obernesser, and F. E. Dewhirst. 1989. Effect of immune cytokines on bone. Immunol. Invest. 18, 239-249 https://doi.org/10.3109/08820138909112240
  26. Taichman, R. S. and P. V. Hauschka. 1992. Effects of interleukin-1 beta and tumor necrosis factor-alpha on osteo-blastic expression of osteocalcin and mineralized extracellular matrix in vitro. Inflammation 16, 587-601 https://doi.org/10.1007/BF00919342
  27. Teitelbaum, S. L. 2000. Bone resorption by osteoclasts. Science 289, 1504-1508 https://doi.org/10.1126/science.289.5484.1504
  28. Tracey, K. J. and A. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45, 491-503 https://doi.org/10.1146/annurev.med.45.1.491
  29. Vilcek, J. and T. H. Lee. 1991. Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J. Biol. Chem. 266, 7313-7316
  30. Wajant, H., K. Pfizenmaier, and P. Scheurich. 2003. Tumor necrosis factor signaling. Cell Death. Differ. 10, 45-65 https://doi.org/10.1038/sj.cdd.4401189
  31. Ziros, P. G., A. P. Gil, T. Georgakopoulos, I. Habeos, D. Kletsas, E. K. Basdra, and A. G. Papavassiliou. 2002. The bone-specific transcriptional regulator Cbfa1 is a target of mechanical signals in osteoblastic cells. J. Biol. Chem. 277, 23934-23941 https://doi.org/10.1074/jbc.M109881200